Effects of leukotriene inhibition on pulmonary morphology in rat pup lungs exposed to hyperoxia

Comparative Medicine

Volumn 57, Issue 2, 2007, Pages 186-192

  Funk, Amy J ^a   Mandrell, Timothy D ^b   Lokey, Sharon J ^b   Kosanke, Stanley D ^c   Li, Chin Shang ^a   Potter, Charles F ^d  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c OKLAHOMA CITY UNIVERSITY   (United States)

^d SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE; OXYGEN; ZAFIRLUKAST; ZILEUTON; DRUG DERIVATIVE; HYDROXYUREA; LEUKOTRIENE RECEPTOR BLOCKING AGENT; TOLUENESULFONIC ACID DERIVATIVE;

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; HYPEROXIA; HYPOXIA; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; LUNG DISEASE; LUNG EDEMA; LUNG HEMORRHAGE; LUNG PARENCHYMA; MALE; NONHUMAN; PUP (RODENT); RAT; SCORING SYSTEM; ANIMAL; CHEMICALLY INDUCED DISORDER; LUNG; NEWBORN; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; FEMALE; HYDROXYUREA; HYPEROXIA; LEUKOTRIENE ANTAGONISTS; LUNG; LUNG DISEASES; MALE; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; TOSYL COMPOUNDS;

EID: 34447257905     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Belik J, Jankov RP, Pan J, Tanswell AK. 2003. Chronic oxygen exposure enhances vascular and airway smooth muscle contraction in the newborn but not the adult rat. J Appl Physiol 94:2303-2312.
2. Bisgaard H. 2001. Leukotriene modifiers in pediatric asthma management. Pediatrics 107:381-390.
3. Carter GW, Young PR, Albert DH, Bouska J, Dyer R, Bell RL, Summers JB, Brooks DW. 1990. 5-Lipoxygenase inhibitory activity of zileuton. J Pharmacol Exp Ther 256:929-937.
4. Crapo JD, Barry BE, Foscue HA, Shelburne J. 1980. Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am Rev Respir Dis 122:123-143.
5. Crapo JD, Peters-Golden M, Marsh-Salin J, Shelburne JS. 1978. Pathologic changes in the lungs of oxygen-adapted rats - a morphometric analysis. Lab Invest 39:640-653.
6. Denis D, Fayon MJ, Berger P, Molimard M, De Lara MT, Roux E, Marthan R. 2001. Prolonged moderate hyperoxia induces hyperresponsiveness and airway inflammation in newborn rats. Pediatr Res 50:515-519.
7. 4 in vitro is decreased for the human neonate. Pediatr Res 33:242-246.
8. Drazen JM, Israel E, O'Byrne PM. 1999. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 340:197-206.
9. Fanaroff A, Martin R. 2002. Neonatal-perinatal medicine, diseases of the fetus and infant, volume 2, Development and disorders of organ systems, 7th ed. St Louis (MO): Mosby. p 1001.
10. Finer NN, Craft A, Vaucher YE, Clark RH, Sola A. 2000. Postnatal steroids: Short-term gain, long-term pain? [Commentary]. J Pediatr 137:9-13.
11. Fost DA, Spahn JD. 1998. The leukotriene modifiers: A new class of asthma medication. Contemp Pediatr 15:1-13.
12. Frank L, Bucher JR, Roberts RJ. 1978. Oxygen toxicity in neonatal and adult animals of various species. J Appl Physiol 45:699-704.
13. Furman L, Hack M, Watts C, Borawski-Clark E, Baley J, Amini S, Hook B. 1995. Twenty-month outcome in ventilator-dependent, very low birth weight infants born during the early years of dexamethasone therapy. J Pediatr 126:434-440.
14. Hageman JR, Zemaitis J, Holtzman RB, Lee SE, Smith LJ, Hunt CE. 1988. Failure of non-selective inhibition of arachidonic acid metabolism to ameliorate hyperoxic lung injury. Prostaglandins Leukot Essent Fatty Acids 32:145-153.
15. 2 for 7 days. J Appl Physiol 51:1220-1231.
16. Jobe A, Bancalari HE. 2001. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163:1723-1729.
17. Jones JE, Walker JL, Song Y, Weiss N, Carduso WV, Tuder RM, Loscalzo J, Zhang YY. 2004. Effect of 5-Lipoyxgenase on the development of pulmonary hypertension in rats. Am J Physiol Heart Circ Physiol 286:H1775-H1784.
18. Kao LC, Warburton D, Platzker ACG, Keens TG. 1984. Effect of isoproterenol inhalation on airway resistance in chronic bronchopulmonary dysplasia. Pediatrics 73:509-514.
19. Kertesz NJ, Holtzman B, Adler L, Hageman JR.1992. Evaluation of a leukotriene receptor antagonist in prevention of hyperoxic lung injury in newborn rabbits. Prostaglandins Leukot Essent Fatty Acids 45:159-162.
20. Laughlin MJ, Wild L, Nickerson PA, Matalon S. 1986. Effects of hyperoxia on alveolar permeability of neutropenic rabbits. J Appl Physiol 61:1126-1131.
21. Lipworth BJ. 1999. Leukotriene-receptor antagonists. Lancet North Am Ed 353:57-62.
22. 4 production during hypoxic pulmonary vasoconstriction in isolated rat lungs. Prostaglandins 28:867-875.
23. Motoyama EK, Brody JS, Colten HR, Warshaw JB. 1988. Postnatal lung development in health and disease. Am Rev Respir Dis 137:742-746.
24. Namovic MT, Walsh RE, Goodfellow C, Harris RR, Carter GW, Bell RL. 1996. Pharmacological modulation of eosinophil influx into the lungs of Brown Norway rats. Eur J Pharmacol 315:81-88.
25. 4. Respiratory Med 89:607-613.
26. Piperno D, Pacheco Y, Hosni R, Moliere P, Gharib C, Lagarde M, Perrin-Fayolle M.1993. Increased plasma levels of atrial natriuretic factor, renin activity, and leukotriene C4 in chronic obstructive pulmonary disease. Chest 104:454-459.
27. Potter CF, Kuo NT, Farver CF, McMahon JT, Chang CH, Aganti FH, Haxhiu MA, Martin RJ. 1999. Effects of hyperoxia on nitric oxide synthase expression, nitric oxide activity and lung injury in rat pups. Pediatr Res 45:8-13.
28. Raj JU, Hazinski TA, Bland RD. 1985. Oxygen-induced lung microvascular injury in neutropenic rabbits and lambs. J Appl Physiol 58:921-927.
29. Reuters Health. Infant conditions account for 4 out of 10 most costly US hospitalizations. [cited 20 Sep 2000]. Available at www.medscape.com/reuters/prof/2000/09/09.19.
30. Savidge RD, Bui KH, Birmingham BK, Morse JL, Spreen RC. 1998. Metabolism and excretion of zafirlukast in dogs, rats, and mice. Drug Metab Dispos 26:1069-1076.
31. Shenberger JS, Shew RL, Johnson DE. 1997. Hyperoxia-induced airway remodeling and pulmonary neuroendocrine cell hyperplasia in the weanling rat. Pediatr Res 42:539-545.
32. Smith LJ, Shamsuddin M, Anderson J, Hsueh W. 1988. Hyperoxic lung damage in mice: appearance and bioconversion of peptide leukotrienes. J Appl Physiol 64:944-951.
33. Stenmark KR, Eyzaguirre M, Westcott JY, Henson PM, Murphy RC. 1987. Potential role of eicosanoids and PAF in the pathophysiology of bronchopulmonary dysplasia. Am Rev Respir Dis 136:770-772.
34. Stenmark KR, James SL, Voelkel NF, Toews WH, Reeves JT, Murphy RC. 1983. Leukotriene C4 in neonates with hypoxemia and pulmonary hypertension. N Engl J Med 309:77-80.
35. Tryka AF, Witschi H, Gosslee DG, McArthur AH, Clapp NK. 1986. Patterns of cell proliferation during recovery from oxygen injury. Am Rev Respir Dis 133:1055-1059.
36. Uyehara CFT, Pichoff BE, Sim HH, Uemura HS, Nakamura KT. 1993. Hyperoxic exposure enhances airway reactivity of newborn guinea pigs. J Appl Physiol 74:2649-2654.
37. Yeh TF, Lin YJ, Hsieh WS, Lin HC, Lin CH, Chen JY, Kao HA, Chien CH. 1997. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter trial. Pediatrics 100:741-748.